These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 9585190)
1. Vaccine visions and their global impact. Bloom BR; Widdus R Nat Med; 1998 May; 4(5 Suppl):480-4. PubMed ID: 9585190 [No Abstract] [Full Text] [Related]
2. Win-win interactions between the public and private sectors. Batson A Nat Med; 1998 May; 4(5 Suppl):487-91. PubMed ID: 9585192 [No Abstract] [Full Text] [Related]
4. For vaccines, the future is now. Saldarini RJ Nat Med; 1998 May; 4(5 Suppl):485-7. PubMed ID: 9585191 [No Abstract] [Full Text] [Related]
5. Vaccines for children in rich and poor countries. Shann F; Steinhoff MC Lancet; 1999 Sep; 354 Suppl 2():SII7-11. PubMed ID: 10507252 [No Abstract] [Full Text] [Related]
6. Response to "Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences". Proano RA; Jacobson SH; Jokela JA Vaccine; 2011 Jan; 29(4):615; author reply 616. PubMed ID: 21094271 [No Abstract] [Full Text] [Related]
7. Vaccines and global health. Greenwood B; Salisbury D; Hill AV Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2733-42. PubMed ID: 21893534 [TBL] [Abstract][Full Text] [Related]
8. Modern vaccines. Progress towards vaccines we need and do not have. Robbins A Lancet; 1990 Jun; 335(8703):1436-8. PubMed ID: 1972216 [No Abstract] [Full Text] [Related]
9. The concept of herd immunity and the design of community-based immunization programmes. Anderson RM Vaccine; 1992; 10(13):928-35. PubMed ID: 1471414 [TBL] [Abstract][Full Text] [Related]
10. Global vaccine project gets a shot in the arm. Check E Nature; 2005 Jan; 433(7024):345. PubMed ID: 15674258 [No Abstract] [Full Text] [Related]
11. Expanded programme on immunization. Global advisory group--Part I. Wkly Epidemiol Rec; 1993 Jan; 68(1-2):1-6. PubMed ID: 8420544 [No Abstract] [Full Text] [Related]
13. Highly affordable vaccines are critical for our continued efforts to reduce global childhood mortality. Kaufmann SHE Hum Vaccin Immunother; 2019; 15(11):2660-2665. PubMed ID: 30973039 [TBL] [Abstract][Full Text] [Related]
15. Costs of vaccine programs across 94 low- and middle-income countries. Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184 [TBL] [Abstract][Full Text] [Related]
16. Evaluating new vaccines for developing countries. Efficacy or effectiveness? Clemens J; Brenner R; Rao M; Tafari N; Lowe C JAMA; 1996 Feb; 275(5):390-7. PubMed ID: 8569019 [TBL] [Abstract][Full Text] [Related]
17. Drive to vaccinate children in developing countries faces "acute crisis" because of high costs. Moszynski P BMJ; 2010 May; 340():c2576. PubMed ID: 20462931 [No Abstract] [Full Text] [Related]
18. Vaccine candidates for poor nations are going to waste. Kaslow DC; Black S; Bloom DE; Datla M; Salisbury D; Rappuoli R Nature; 2018 Dec; 564(7736):337-339. PubMed ID: 30560957 [No Abstract] [Full Text] [Related]
19. [Vaccinations in Latin America. "The incidence and costs of avoidable diseases"]. Kumate J An Esp Pediatr; 1992 Jun; 36 Suppl 48():195-7. PubMed ID: 1636968 [No Abstract] [Full Text] [Related]